Skip to main navigation Skip to search Skip to main content

A novel truncating variant in the FGD1 gene associated with Aarskog–Scott syndrome in a family previously diagnosed with Tel Hashomer camptodactyly

  • Regeneron Genetics Center
  • Carmel Medical Center
  • Technion-Israel Institute of Technology
  • Bnai-Zion Medical Center
  • Regeneron Pharmaceuticals, Inc.
  • Rambam Health Care Campus Israel
  • Tel Aviv Sourasky Medical Center

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Tel Hashomer camptodactyly syndrome is a long-known entity characterized by camptodactyly with muscular hypoplasia, skeletal dysplasia, and abnormal palmar creases. Currently, the genetic basis for this disorder is unknown, thus there is a possibility that this clinical presentation may be contained within another genetic diagnosis. Here, we present a multiplex family with a previous clinical diagnosis of Tel Hashomer camptodactyly syndrome. Whole exome sequencing and pedigree-based analysis revealed a novel hemizygous truncating variant c.269_270dup (p.Phe91Alafs*34) in the FGD1 gene (NM_004463.3) in all three symptomatic patients, congruous with a diagnosis of Aarskog–Scott syndrome. Our report adds to the limited data on Aarskog–Scott syndrome, and emphasizes the importance of unbiased comprehensive molecular testing toward establishing a diagnosis for genetic syndromes with unknown genetic basis.

Original languageEnglish
Pages (from-to)3161-3166
Number of pages6
JournalAmerican Journal of Medical Genetics, Part A
Volume185
Issue number10
DOIs
StatePublished - Oct 2021

Keywords

  • Aarskog–Scott syndrome
  • genetic diseases
  • whole exome sequencing

Fingerprint

Dive into the research topics of 'A novel truncating variant in the FGD1 gene associated with Aarskog–Scott syndrome in a family previously diagnosed with Tel Hashomer camptodactyly'. Together they form a unique fingerprint.

Cite this